This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
This week in health care news: An interview with the fired HHS watchdog, inside ...
Canadian officials have obtained a court order that requires Express Scripts to ...
Signs of potential liver damage in a study participant led the company to abando...
In a Friday speech to FDA employees, the HHS secretary laid bare his belief that...
The Atlas-backed company plans to liquidate its assets, including an experimenta...
Human medicines European public assessment report (EPAR): Capvaxive, pneumococca...
J&J received a thumbs-up from the FDA last fall to launch human trials of the sy...
Human medicines European public assessment report (EPAR): Lyvdelzi (previously S...
As first quarter earnings begin, executives are confronting market turmoil, regu...
Sandoz has filed an antitrust lawsuit in federal court in Virginia claiming that...
Agenda of the CAT meeting 14-16 April 2025
Human medicines European public assessment report (EPAR): Stelara, ustekinumab, ...
Evaluation of medicinal products indicated for treatment of bacterial infections...
Wall Street analysts said the results for Verve’s therapy appeared competitive o...
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,co...
Ironwood Pharmaceuticals has been left considering its options after the FDA dem...
The annual meeting of the American College of Physicians (Internal Medicine Meet...
MONDAY, April 14, 2025 -- Adherence to American Cancer Society (ACS) nutrition ...
MONDAY, April 14, 2025 -- Medial temporal lobectomy is effective in improving s...
MONDAY, April 14, 2025 -- For patients with breast cancer, the brain functional...
MONDAY, April 14, 2025 -- Low oral health scores are associated with higher pai...
MONDAY, April 14, 2025 -- Women and individuals with a paternal history of Alzh...
MONDAY, April 14, 2025 -- A prostate cancer screening program involving partici...